- Home
- NAAS vs VNRX Comparison
NAAS vs VNRX Comparison
Compare NAAS & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NAAS | VNRX |
|---|---|---|
| Founded | 2019 | N/A |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.8M | 38.2M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | NAAS | VNRX |
|---|---|---|
| Price | $3.23 | $0.29 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | 23.5K | ★ 2.2M |
| Earning Date | 03-31-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $21,817,052.00 | $1,472,007.00 |
| Revenue This Year | $378.49 | $55.98 |
| Revenue Next Year | N/A | $420.37 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 14.48 |
| 52 Week Low | $1.96 | $0.22 |
| 52 Week High | $40.32 | $0.94 |
Technical Indicators
Market Signals| Indicator | NAAS | VNRX |
|---|---|---|
| Relative Strength Index (RSI) | 44.56 | 47.78 |
| Support Level | $3.01 | $0.31 |
| Resistance Level | $3.30 | $0.39 |
| Average True Range (ATR) | 0.19 | 0.03 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 50.43 | 41.70 |
Price Performance
Historical ComparisonAbout NAAS NaaS Technology Inc.
Naas Technology Inc is an electric vehicle charging service provider in China, whose vision is to power the world with carbon-neutral energy. It offers an integrated set of online solutions to charging station operators, a wide range of offline services that simplify the daily operations of charging station operators, and non-charging services such as food and beverage services to station operators.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.